enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Tiagabine - Wikipedia

   en.wikipedia.org/wiki/Tiagabine

   Tiagabine is approved by U.S. Food and Drug Administration (FDA) as an adjunctive treatment for partial seizures in individuals of age 12 and up. It may also be prescribed off-label by physicians to treat anxiety disorders and panic disorder as well as neuropathic pain (including fibromyalgia). For anxiety and neuropathic pain, tiagabine is ...

3. Fibromyalgia - Wikipedia

   en.wikipedia.org/wiki/Fibromyalgia

   However, this medication was not approved by the FDA for the indication for use in people with fibromyalgia due to the concern for abuse. [ 193 ] The muscle relaxants cyclobenzaprine , carisoprodol with acetaminophen and caffeine, and tizanidine are sometimes used to treat fibromyalgia; however, as of 2015 they are not approved for this use in ...

4. Tinnitus - Wikipedia

   en.wikipedia.org/wiki/Tinnitus

   In March 2023, the US Food and Drug Administration (FDA) approved Neuromod's Lenire device as a treatment option for tinnitus. [ 130 ] [ 131 ] [ 132 ] In June 2024, the US Department of Veterans Affairs (VA) announced it would begin offering the treatment to veterans with tinnitus, making it the first bimodal neuromodulation device to be ...

5. Pregabalin - Wikipedia

   en.wikipedia.org/wiki/Pregabalin

   Pregabalin, sold under the brand name Lyrica among others, is an anticonvulsant, analgesic, and anxiolytic amino acid medication used to treat epilepsy, neuropathic pain, fibromyalgia, restless legs syndrome, opioid withdrawal, and generalized anxiety disorder (GAD).

6. Retigabine - Wikipedia

   en.wikipedia.org/wiki/Retigabine

   The U.S. Food and Drug Administration accepted Valeant's New Drug Application for retigabine on December 30, 2009. [20] The FDA Peripheral and Central Nervous System Drugs Advisory Committee met on August 11, 2010, to discuss the process and unanimously recommended approval of Potiga for the intended indication (add-on treatment of partial ...

7. Zepbound Weight Loss Medication Approved by FDA to Treat ...

   www.aol.com/fda-approves-weight-loss-medication...

   The weight loss drug Zepbound, generically known as tirzepatide, is also now an approved medication to treat obstructive sleep apnea, per a Food and Drug Administration Dec. 20 press release. The ...